For the year ending 2025-12-31, APLS has $1,075,257K in assets. $705,110K in debts. $466,233K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and cash equivalents | 466,233 | 411,290 | 351,185 | 551,801 |
| Accounts receivable | 366,221 | 264,926 | 206,442 | 7,727 |
| Inventory | 142,556 | 81,404 | 146,362 | 85,714 |
| Prepaid assets | - | 18,368 | 38,820 | 36,350 |
| Prepaid and other current assets | 38,303 | - | - | - |
| Restricted cash | 1,527 | 1,322 | 1,114 | 1,273 |
| Other current assets | - | 11,644 | 22,408 | 36,658 |
| Total current assets | 1,014,840 | 788,954 | 766,331 | 719,523 |
| Right-of-use assets | 18,195 | 16,083 | 16,745 | 18,747 |
| Property and equipment, net | 1,708 | 2,952 | 4,345 | 6,148 |
| Long-term inventory | 34,959 | 75,713 | - | - |
| Other assets | 5,555 | 1,349 | 1,309 | 15,799 |
| Total assets | 1,075,257 | 885,051 | 788,730 | 760,217 |
| Accounts payable | 56,798 | 38,572 | 37,516 | 37,342 |
| Accrued expenses | 166,049 | 140,184 | 127,806 | 95,139 |
| Current portion of development liability | - | - | 75,830 | 29,504 |
| Convertible senior notes | 93,662 | - | - | - |
| Current portion of lease liabilities | 7,087 | 6,753 | 6,441 | 5,625 |
| Total current liabilities | 323,596 | 185,509 | 247,593 | 167,610 |
| Long-term development liability | - | - | 239,817 | 315,647 |
| Long-term credit facility | 361,664 | 359,489 | - | - |
| Convertible senior notes | 0 | 93,341 | 93,033 | 92,736 |
| Lease liabilities | 11,947 | 10,201 | 11,454 | 14,352 |
| Other liabilities | 7,903 | 7,972 | 2,312 | - |
| Total liabilities | 705,110 | 656,512 | 594,209 | 590,345 |
| Common stock, 0.0001 par value 200,000 shares authorized at december 31, 2025 and 2024 126,621 and 124,495 shares issued and outstanding at december 31, 2025 and 2024, respectively | 12 | 12 | 12 | 11 |
| Additional paid-in capital | 3,385,216 | 3,267,201 | 3,035,539 | 2,479,596 |
| Accumulated other comprehensive loss | -2,103 | -3,308 | -3,542 | -875 |
| Accumulated deficit | -3,012,978 | -3,035,366 | -2,837,488 | -2,308,860 |
| Total stockholders equity | 370,147 | 228,539 | 194,521 | 169,872 |
| Total liabilities and stockholders equity | 1,075,257 | 885,051 | 788,730 | 760,217 |
Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc. (APLS)